Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > mdjbrown...agree, be it today or 30 years ago on a posting
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(171)
•••
Comment by QContinuum1on Mar 15, 2024 4:38pm
74 Views
Post# 35935719

RE:mdjbrown...agree, be it today or 30 years ago on a posting

RE:mdjbrown...agree, be it today or 30 years ago on a posting
I have over 1.5e6 shares as well and yet don't believe that Pidduck ever said anything about 'late stage' products in the drug pipeline and can also substantiate that with NR proof. 

While I agree that Pidduck stated profitability expectations early in 2024, they have since walked that back per what Lemoyne mentions.  So no, they will not be profitable in Q1 as they stated post Vivo merger but I would expect that some time in 2024 if they are to be believed.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities